Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

LVMH Shares Poised for Potential Rebound as Goldman Sachs Raisises Outlook

Robert Sasse by Robert Sasse
September 27, 2025
in Analysis, Consumer & Luxury, European Markets, Turnaround
0
LVMH Stock
0
SHARES
103
VIEWS
Share on FacebookShare on Twitter

Investment firm Goldman Sachs has upgraded its assessment of luxury conglomerate LVMH, suggesting the company may be emerging from a challenging period. The bank has increased its price target for the shares from €600 to €625, maintaining a positive ‘buy’ recommendation for investors.

Analyst Confidence Rises on Improved Sector Outlook

The most significant driver behind this optimistic shift is the anticipated performance of LVMH’s crucial Fashion & Leather Goods division. Goldman Sachs analysts project a notable sequential improvement for the third quarter, believing the segment has moved past its most severe difficulties. Their forecast anticipates a more modest revenue decline of approximately 2% for Q3, which is notably more favorable than the broader market consensus projecting a 3% drop.

This improved outlook is attributed to two key factors: more favorable year-over-year comparisons and early indicators of a demand recovery among Chinese consumers, a critical demographic for the luxury sector.

Strategic Moves During Downturn May Yield Advantages

While the global luxury market continues to experience slower growth, LVMH’s recent strategic initiatives are highlighted as potential catalysts. The launch of LV Beauté, a high-profile partnership with Formula 1, and the development of innovative retail concepts are seen as strategic investments that could now begin to attract new customer segments and drive growth.

Should investors sell immediately? Or is it worth buying LVMH?

These proactive measures, implemented during the market’s weakness, are positioned to provide LVMH with a competitive edge as conditions improve.

All Eyes on the Core Fashion Division’s Recovery

The Fashion & Leather Goods unit remains the cornerstone of LVMH’s business, making its trajectory vital for the overall company’s health. Following a sharp 9% revenue contraction in the second quarter, the market is keenly watching for signals of a turnaround. Any positive development in this division is expected to be received favorably by investors.

Key factors supporting a potential recovery include:
* A demand rebound in the strategically important Chinese market
* Consumer trends favoring “quiet luxury,” which align well with LVMH’s brand portfolio
* Continued robust growth in the Japanese market, demonstrating regional strength
* The long-term benefit of the company’s strategic positioning during the recent industry-wide challenges

The central question for investors is whether LVMH can leverage its historical resilience to reassert its leadership within the luxury goods industry.

Ad

LVMH Stock: Buy or Sell?! New LVMH Analysis from March 25 delivers the answer:

The latest LVMH figures speak for themselves: Urgent action needed for LVMH investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

LVMH: Buy or sell? Read more here...

Tags: LVMH
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
Fair Isaac Stock
Analysis

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Next Post
Bloom Energy Stock

Bloom Energy Shares Face Steep Decline Amid Analyst Downgrade

DexCom Stock

DexCom Shares Face Mounting Challenges Amid Regulatory Setbacks and Leadership Uncertainty

Verona Pharma Stock

Verona Pharma Acquisition Nears Final Approval Following Shareholder Vote

Recommended

Nike Stock

Nike Faces Critical Test as Quarterly Results Approach

6 months ago
Opendoor Stock

Opendoor Shares Plunge as Investor Confidence Evaporates

4 months ago
QuantumScape Stock

QuantumScape’s Stock Under Pressure: Can Innovation Outpace Market Doubts?

4 months ago
NASDAQ 100 Stock

Tech Giants Face Reality Check as AI Costs Rattle Nasdaq 100

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Trending

Dell Stock
AI & Quantum Computing

Dell’s Quantum Security Push Amidst AI-Driven Growth

by Kennethcix
March 25, 2026
0

Dell Technologies is fortifying its hardware portfolio for the dual challenges of quantum computing and artificial intelligence....

Gossamer Bio Stock

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

March 25, 2026
SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Dell’s Quantum Security Push Amidst AI-Driven Growth
  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com